Step One: 

Review the Protocol Submission Form Instructions and FAQs (.PDF) to determine what level of review your study requires. 

Tip: this interactive Protocol Review and Monitoring System Pathways presentation (.PPTX) presentation provides a  summary of the pathways for protocol review (view in 'presentation mode' to click through the different approaches). 

Step Two: 

Reach out to the clinical trials office: 

• For industry-sponsored trials: email Emma Armstrong, Study Activation Specialist at emma.armstrong@uvmhealth.org.
• For investigator-initiated trials: for support with protocol and/or budget review email Tracy Smith, Ph.D. Protocol Writer and Activation Specialist at tracy.smith@med.uvm.edu. 

Step Three: 

If required, complete the First Stage Review Protocol Submission Form (.PDF) for the Transdisciplinary Team (TDT) first stage study review. 

• For investigators: See a the directory of transdisciplinary teams and leaders.
• For Transdisciplinary Team Leaders: access the TDT New Protocol Review (.PDF)

Step Four:

If required, complete the Investigator-Initiated Trial Treatment Protocol Template (.DOC) 

• Learn more about the Protocol Review and Monitoring Committee.
• Learn more about Clinical Trials services for UVM Cancer Center members. 

Our Study Activation Team 

Tracy Smith MSc, PHD

Role: Faculty Scientist 

Email: tracy.smith@med.uvm.edu

Emma Armstrong ACRP-CP

Role: Oncology Clinical Trials Specialist 

Email: emma.armstrong@uvmhealth.org